PHARMACEUTICAL DOSAGE FORM BASED ON AN OSMOTIC ACTIVE INGREDIENT RELEASE SYSTEM COMPRISING AN ACTIVE INGREDIENT COMBINATION OF NIFEDIPINE AND/OR NISOLDIPINE AND AN ANGIOTENSIN II ANTAGONIST

The present invention relates to a pharmaceutical dosage form based on an osmotic active ingredient release system comprising an active ingredient combination of nifedipine and/or nisoldipine and at least one angiotensin II antagonist, wherein the active ingredient combination undergoes controlled (...

Full description

Saved in:
Bibliographic Details
Main Authors HUETTER, JOACHIM, BENKE, KLAUS, TINEL, HANNA, OHM, ANDREAS
Format Patent
LanguageEnglish
French
Published 15.10.2013
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a pharmaceutical dosage form based on an osmotic active ingredient release system comprising an active ingredient combination of nifedipine and/or nisoldipine and at least one angiotensin II antagonist, wherein the active ingredient combination undergoes controlled (modified) release in the body, and to processes for the production thereof, to the use thereof as pharmaceuticals, to the use thereof for the prophylaxis, secondary prophylaxis and/or treatment of disorders, and to the use thereof for manufacturing a pharmaceutical for the prophylaxis, secondary prophylaxis and/or treatment of disorders.
Bibliography:Application Number: CA20062614085